The observations suggest that the SARS-CoV-2 Mpro may be inducing an insulin-resistant state and dysregulation of glucose metabolism. Further studies are warranted to fully elucidate the mechanisms underlying the development of new-onset diabetes mellitus in patients with a history of COVID-19.
Nhau et al. (Sun,) studied this question.